Contrary to the findings in bladder cancer cells, NR4A2 is shown to promote growth of colorectal cancer [20] and to transactivate osteopontin, a direct target of the Wnt/β-catenin pathway associated with colorectal invasion and metastasis [21]. This evidence concerns the gene NR4A2 and urinary bladder cancer.